ICU Medical (ICUI) Tops Q2 EPS by 60c, provides guidance

ICU Medical (NASDAQ: ICUI) reported Q2 EPS of $2.10, $0.60 better than the analyst estimate of $1.50. Revenue for the quarter came in at $548.9 million versus the consensus estimate of $540.1 million.

GUIDANCE:

ICU Medical sees Q3 2025 EPS of ($1.68)-($1.38), versus the consensus of $1.49.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Kimbell Royalty closes $221.2M mineral rights acquisition
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics